Sevelamer Overview and Management

What classification is sevelamer (Renagel)?

What is the mechanism of action for sevelamer (Renagel)?

What are indications for sevelamer (Renagel)?

What route is sevelamer (Renagel) given?

What are contraindications for sevelamer (Renagel)?

What are adverse effects of sevelamer (Renagel)?

What labs should be monitored for sevelamer (Renagel)?

What are 2 priority assessments for sevelamer (Renagel)?

Sevelamer (Renagel) Overview

Sevelamer is classified as a phosphate binder, used primarily in the management of elevated phosphate levels.
It works by binding phosphate in the gastrointestinal tract to prevent its absorption into the bloodstream.

Indications and Usage

Prescribed for managing hyperphosphatemia related to end-stage renal disease (ESRD) and chronic renal failure.
Typically administered orally, ensuring patient compliance with dosing.

Contraindications

Not suitable for patients with bowel obstruction, as phosphate is excreted via feces.
Should be avoided in individuals with hypophosphatemia due to the risk of exacerbating low phosphate levels.

Adverse Effects

Common side effects include nausea, vomiting, diarrhea, and constipation, which may impact patient adherence.

Monitoring and Assessments

Regular monitoring of phosphate levels is crucial to evaluate treatment efficacy.
Two priority assessments include ensuring the medication is taken with meals and instructing patients not to chew or open capsules to maintain efficacy and safety.

This quiz covers Sevelamer, a phosphate binder used in the management of elevated phosphate levels, particularly in patients with end-stage renal disease. Learn about its indications, contraindications, adverse effects, and the importance of monitoring phosphate levels for effective treatment. Test your understanding of this essential medication.